Credit Agricole’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-3,700
Closed -$160K 1512
2015
Q3
$160K Sell
3,700
-1,000
-21% -$42.2K ﹤0.01% 1324
2015
Q2
$198K Buy
4,700
+3,700
+370% +$156K ﹤0.01% 1277
2015
Q1
$39K Sell
1,000
-4,300
-81% -$166K ﹤0.01% 1431
2014
Q4
$181K Hold
5,300
﹤0.01% 1415
2014
Q3
$186K Sell
5,300
-1,800
-25% -$61.7K ﹤0.01% 1376
2014
Q2
$233K Sell
7,100
-2,900
-29% -$99.2K ﹤0.01% 1365
2014
Q1
$369K Sell
10,000
-111,199
-92% -$4.08M ﹤0.01% 1187
2013
Q4
$4.65M Buy
121,199
+35,380
+41% +$1.12M 0.02% 629
2013
Q3
$2.35M Buy
+85,819
New +$2.03M 0.01% 798

Other funds holding WX

Credit Agricole's WX Position: Q4 2015 in Review

Credit Agricole sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 3,700 shares — an estimated $160K sold.

Credit Agricole first reported a position in WX in Q3 2013 and held it in 9 quarters. The position peaked at $4.65M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Credit Agricole reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Credit Agricole sold 3,700 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $160K.
  • Credit Agricole first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 9 quarters.
  • Credit Agricole's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4.65M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Credit Agricole's 13F filing for Q4 2015, filed 11 Feb 2016.